< Back to latest news & events

News

More Exam Success at HGF!

March 2024

HGF is delighted to announce success for many of our colleagues in the recent exams and to congratulate them on this fantastic achievement.

Martyn Fish CEO comments, “These exams are extremely challenging so I would like to personally congratulate everyone on their success!”

In no specific order, we would like to say well done and a huge congratulations to the following people:

The firm would also like to take this opportunity to thank our tutors and mentors for their contribution in helping others prepare for the exams and ultimately help colleagues to progress.

Tutors

Mentors

Lucy Johnson Chair comments, “Thank you for bringing our values to life, you have all given your time to support your colleagues and ultimately progress their careers. I would like to say thank you from your colleagues, myself and the wider shareholder group.”

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article